Literature DB >> 6315960

Production of free radicals and lipid peroxides in early experimental myocardial ischemia.

P S Rao, M V Cohen, H S Mueller.   

Abstract

Free radicals and lipid peroxides have recently been identified by us [1, 2, 3] as metabolic intermediates during acute myocardial ischemia. The mechanisms by which evolving myocardial ischemia initiates free radical production are not clear. Based on studies in vitro, it is feasible to consider the following possibilities: (a) dissociation of intramitochondrial electron support system and altered phospholipid integrity with inactivation of cytochrome oxidase, which results in release of ubisemiquinone, flavoprotein and superoxide radicals; (b) accumulation and increased release of intra/extracellular metabolites like NADH, lactate flavoproteins and catecholamines which react either with themselves or with O2 and ascorbic acid; (c) interaction of the metabolic product hypoxanthine with O2 in the presence of xanthine oxidase and (d) activation of phospholipase by calcium influx with enhanced arachidonic acid metabolism and superoxide radical production. Detailed in vitro radiobiological studies [4] have demonstrated that free radical reactions occur even at very low O2 tensions (83% of maximum rate of PO2 approximately 6 mmHg and 50% at PO2 approximately 1 mmHg), and Smith [5] has demonstrated that free radical peroxidation takes place quite rapidly in rat brain homogenates incubated in gas mixtures containing only 5% O2. Thus, the low oxygen tensions in ischemic tissue are adequate to support free radical reactions. The free radicals thus produced may initiate and enhance lipid peroxidation by attacking polyunsaturated membrane lipids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315960     DOI: 10.1016/0022-2828(83)90260-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  46 in total

1.  Effects of oxyradicals on oxymyoglobin. Deoxygenation, haem removal and iron release.

Authors:  M R Prasad; R M Engelman; R M Jones; D K Das
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

2.  Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart.

Authors:  D Di Pierro; B Tavazzi; G Lazzarino; B Giardina
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 3.  Reactive oxygen metabolites and the human myocardium.

Authors:  C J Burrell; D R Blake
Journal:  Br Heart J       Date:  1989-01

Review 4.  Use of electron paramagnetic resonance spectroscopy to evaluate the redox state in vivo.

Authors:  Harold M Swartz; Nadeem Khan; Valery V Khramtsov
Journal:  Antioxid Redox Signal       Date:  2007-10       Impact factor: 8.401

5.  Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

Authors:  D Bani; E Masini; M G Bello; M Bigazzi; T B Sacchi
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

6.  Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2009

Review 7.  Free radicals as endogenous histamine releasers.

Authors:  P F Mannaioni; E Giannella; B Palmerani; A Pistelli; F Gambassi; T Bani-Sacchi; S Bianchi; E Masini
Journal:  Agents Actions       Date:  1988-04

Review 8.  Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy.

Authors:  Nadeem Khan; Harold Swartz
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Does the antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure of the molecule itself?

Authors:  A Tosaki; R F Haseloff; A Hellegouarch; K Schoenheit; V V Martin; D K Das; I E Blasig
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

10.  Failure of allopurinol and a spin trapping agent N-t-butyl-alpha-phenyl nitrone to modify significantly ischaemia and reperfusion-induced arrhythmias.

Authors:  J R Parratt; C L Wainwright
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.